Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury
Noninvasive, affordable circulating biomarkers for difficult-to-diagnose mild traumatic brain injury (mTBI) are an unmet medical need. Although blood microRNA (miRNA) levels are reportedly altered after traumatic brain injury (TBI), their diagnostic potential for mTBI remains inconclusive. We hypoth...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/4/1563 |
_version_ | 1797415075102851072 |
---|---|
author | Shalini Das Gupta Robert Ciszek Mette Heiskanen Niina Lapinlampi Janne Kukkonen Ville Leinonen Noora Puhakka Asla Pitkänen |
author_facet | Shalini Das Gupta Robert Ciszek Mette Heiskanen Niina Lapinlampi Janne Kukkonen Ville Leinonen Noora Puhakka Asla Pitkänen |
author_sort | Shalini Das Gupta |
collection | DOAJ |
description | Noninvasive, affordable circulating biomarkers for difficult-to-diagnose mild traumatic brain injury (mTBI) are an unmet medical need. Although blood microRNA (miRNA) levels are reportedly altered after traumatic brain injury (TBI), their diagnostic potential for mTBI remains inconclusive. We hypothesized that acutely altered plasma miRNAs could serve as diagnostic biomarkers both in the lateral fluid percussion injury (FPI) model and clinical mTBI. We performed plasma small RNA-sequencing from adult male Sprague–Dawley rats (<i>n</i> = 31) at 2 days post-TBI, followed by polymerase chain reaction (PCR)-based validation of selected candidates. miR-9a-3p, miR-136-3p, and miR-434-3p were identified as the most promising candidates at 2 days after lateral FPI. Digital droplet PCR (ddPCR) revealed 4.2-, 2.8-, and 4.6-fold elevations in miR-9a-3p, miR-136-3p, and miR-434-3p levels (<i>p</i> < 0.01 for all), respectively, distinguishing rats with mTBI from naïve rats with 100% sensitivity and specificity. DdPCR further identified a subpopulation of mTBI patients with plasma miR-9-3p (<i>n</i> = 7/15) and miR-136-3p (<i>n</i> = 5/15) levels higher than one standard deviation above the control mean at <2 days postinjury. In sTBI patients, plasma miR-9-3p levels were 6.5- and 9.2-fold in comparison to the mTBI and control groups, respectively. Thus, plasma miR-9-3p and miR-136-3p were identified as promising biomarker candidates for mTBI requiring further evaluation in a larger patient population. |
first_indexed | 2024-03-09T05:42:48Z |
format | Article |
id | doaj.art-0a5b373e9b214357bb68bccfffb13c93 |
institution | Directory Open Access Journal |
issn | 1661-6596 1422-0067 |
language | English |
last_indexed | 2024-03-09T05:42:48Z |
publishDate | 2021-02-01 |
publisher | MDPI AG |
record_format | Article |
series | International Journal of Molecular Sciences |
spelling | doaj.art-0a5b373e9b214357bb68bccfffb13c932023-12-03T12:23:05ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-02-01224156310.3390/ijms22041563Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain InjuryShalini Das Gupta0Robert Ciszek1Mette Heiskanen2Niina Lapinlampi3Janne Kukkonen4Ville Leinonen5Noora Puhakka6Asla Pitkänen7A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, FinlandA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, FinlandA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, FinlandA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, FinlandDepartment of Neurosurgery, Kuopio University Hospital, 70029 Kuopio, FinlandDepartment of Neurosurgery, Kuopio University Hospital, 70029 Kuopio, FinlandA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, FinlandA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, FinlandNoninvasive, affordable circulating biomarkers for difficult-to-diagnose mild traumatic brain injury (mTBI) are an unmet medical need. Although blood microRNA (miRNA) levels are reportedly altered after traumatic brain injury (TBI), their diagnostic potential for mTBI remains inconclusive. We hypothesized that acutely altered plasma miRNAs could serve as diagnostic biomarkers both in the lateral fluid percussion injury (FPI) model and clinical mTBI. We performed plasma small RNA-sequencing from adult male Sprague–Dawley rats (<i>n</i> = 31) at 2 days post-TBI, followed by polymerase chain reaction (PCR)-based validation of selected candidates. miR-9a-3p, miR-136-3p, and miR-434-3p were identified as the most promising candidates at 2 days after lateral FPI. Digital droplet PCR (ddPCR) revealed 4.2-, 2.8-, and 4.6-fold elevations in miR-9a-3p, miR-136-3p, and miR-434-3p levels (<i>p</i> < 0.01 for all), respectively, distinguishing rats with mTBI from naïve rats with 100% sensitivity and specificity. DdPCR further identified a subpopulation of mTBI patients with plasma miR-9-3p (<i>n</i> = 7/15) and miR-136-3p (<i>n</i> = 5/15) levels higher than one standard deviation above the control mean at <2 days postinjury. In sTBI patients, plasma miR-9-3p levels were 6.5- and 9.2-fold in comparison to the mTBI and control groups, respectively. Thus, plasma miR-9-3p and miR-136-3p were identified as promising biomarker candidates for mTBI requiring further evaluation in a larger patient population.https://www.mdpi.com/1422-0067/22/4/1563biomarkermicroRNAmild TBImiR-9-3pmiR-136-3pplasma |
spellingShingle | Shalini Das Gupta Robert Ciszek Mette Heiskanen Niina Lapinlampi Janne Kukkonen Ville Leinonen Noora Puhakka Asla Pitkänen Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury International Journal of Molecular Sciences biomarker microRNA mild TBI miR-9-3p miR-136-3p plasma |
title | Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury |
title_full | Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury |
title_fullStr | Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury |
title_full_unstemmed | Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury |
title_short | Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury |
title_sort | plasma mir 9 3p and mir 136 3p as potential novel diagnostic biomarkers for experimental and human mild traumatic brain injury |
topic | biomarker microRNA mild TBI miR-9-3p miR-136-3p plasma |
url | https://www.mdpi.com/1422-0067/22/4/1563 |
work_keys_str_mv | AT shalinidasgupta plasmamir93pandmir1363paspotentialnoveldiagnosticbiomarkersforexperimentalandhumanmildtraumaticbraininjury AT robertciszek plasmamir93pandmir1363paspotentialnoveldiagnosticbiomarkersforexperimentalandhumanmildtraumaticbraininjury AT metteheiskanen plasmamir93pandmir1363paspotentialnoveldiagnosticbiomarkersforexperimentalandhumanmildtraumaticbraininjury AT niinalapinlampi plasmamir93pandmir1363paspotentialnoveldiagnosticbiomarkersforexperimentalandhumanmildtraumaticbraininjury AT jannekukkonen plasmamir93pandmir1363paspotentialnoveldiagnosticbiomarkersforexperimentalandhumanmildtraumaticbraininjury AT villeleinonen plasmamir93pandmir1363paspotentialnoveldiagnosticbiomarkersforexperimentalandhumanmildtraumaticbraininjury AT noorapuhakka plasmamir93pandmir1363paspotentialnoveldiagnosticbiomarkersforexperimentalandhumanmildtraumaticbraininjury AT aslapitkanen plasmamir93pandmir1363paspotentialnoveldiagnosticbiomarkersforexperimentalandhumanmildtraumaticbraininjury |